Macrophage activation syndrome due to juvenile amyopathic dermatomyositis with atypical onset
Turkderm Turkish Archives of Dermatology and Venereology, ISSN: 2651-5164, Vol: 56, Issue: 2, Page: 84-87
2022
- 1Citations
- 5Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Macrophage activation syndrome (MAS) is a life-threatening condition associated with rheumatic diseases. It is rarely reported in juvenile dermatomyositis. An 8-year-old girl was admitted with complaints of joint swelling and psoriasiform plaques on the elbows. She was diagnosed with psoriatic arthritis, and methotrexate therapy was started. Three months later, she was readmitted with fever, fatigue, and weight loss. Hepatosplenomegaly was found on physical examination. The muscle strengths were 5/5. Dermatological examination revealed facial edema, widespread maculoerythematous rash, and xerosis. Erythematous-violaceous papulosquamous plaques were seen on the dorsal surfaces of the elbows and metacarpophalangeal and proximal interphalangeal joints. Based on the clinical and laboratory findings, the patient was considered to have MAS secondary to juvenile amyopathic dermatomyositis (JADM). The cutaneous manifestations seen in MAS are not specific but depend on the underlying rheumatic disease. Given the atypical onset, this was considered a case of JADM misdiagnosed as psoriasis, which rapidly progressed to MAS.
Bibliographic Details
Galenos Yayinevi
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know